Ensoma
Develops a genomic medicine platform for in vivo engineering of hematopoietic stem cells.
$50M Series B+ ·
Source: fundraisingfox.com
All 2 rounds ↓Signals
X account@EnsomaBio · created Jun 26, 2020 (6 years old) · 356 followers
Website registeredMay 11, 2003 (23 years old)
TIMELINE · MONEY RAISED
Ensoma | 928 days from X account to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $50M | — | fundraisingfox.com | |
| Series B+ | undisclosed | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
AL
Andre Lieber FounderHP
Hans Peter Kiem FounderEF
Emile F. Nuwaysir CEOJG
Jon Garen Chief Corporate Development and Business OfficerMW
Min Wang Chief Operating Officer
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| Not disclosed publicly | Date not given |
Investors
BBill & Melinda Gates Foundation
- BBioluminescence Ventures
CCormorant Asset Management
DDelos Capital
FF-Prime Capital
GGilead Sciences
KKite Pharma
MMirae Asset Financial GroupRRTW Investments
SSolasta Ventures
SSymBiosis
VViking Global Investors
Companies like Ensoma
IInnornaSeries B+ · Apr 2022RRejuvStemSeed · Sep 2026
NNewLimit$435M Series B+ · Jun 2026
IInfinimmuneSeries A
UUmoja Biopharma$100M Series B+ · Jan 2025
NnChroma Bio$75M · Dec 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ensoma (get a free API key).